The Federal Trade Commission said the deal would enable Amgen to “entrench” the monopoly positions of two Horizon drugs that lack competition.
Posted inBusiness
U.S. Sues to Block Amgen’s $27.8 Billion Takeover of Horizon Therapeutics
The Federal Trade Commission said the deal would enable Amgen to “entrench” the monopoly positions of two Horizon drugs that lack competition.